ACTIVE

HOSPITAL PHARMACY CONSULTING BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result96,1 k €+37,9 %over 1 year
Gross margin148,1 k €+43,8 %over 1 year
Equity216,8 k €+36,9 %over 1 year

Identity

Source · BCE/KBO

HOSPITAL PHARMACY CONSULTING BELGIUM is a Private limited company incorporated in 2012. Its main activity is: Public relations and communication activities. Its registered office is in Bierbeek.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0846.455.454
Incorporation
04/06/2012
Legal form
Private limited company
Registered office
Waversesteenweg(OPV) 31
3360 Bierbeek · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 14 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin148,1 k €103 k €115,2 k €87,3 k €83,1 k €
EBITDA147,9 k €103 k €115,2 k €87,3 k €83,1 k €
Operating result135,6 k €88,4 k €100,9 k €72,5 k €68,7 k €
Net result96,1 k €69,7 k €80,9 k €52,1 k €49,9 k €
Balance sheet
Equity216,8 k €158,3 k €192,9 k €238,6 k €219 k €
Total assets279,2 k €281,8 k €341,3 k €290,4 k €281,4 k €
Cash189,6 k €210,8 k €255,5 k €192,5 k €170,1 k €
Debts62,4 k €123,5 k €148,4 k €50,7 k €61,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Hendrik Merckx
Directorsince 04/06/2012Managersince 04/06/2012ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/06/202608/07/202502/07/202406/07/202327/07/202230/07/2021
General meeting09/06/202610/06/202511/06/202413/06/202314/06/202208/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202509/06/202619/06/2026DutchPDF
Micro model31/12/202410/06/202508/07/2025DutchPDF
Micro model31/12/202311/06/202402/07/2024DutchPDF
Micro model31/12/202213/06/202306/07/2023DutchPDF
Micro model31/12/202114/06/202227/07/2022DutchPDF
Micro model31/12/202008/06/202130/07/2021DutchPDF
Micro model31/12/201909/06/202031/07/2020DutchPDF
Micro model31/12/201811/06/201931/07/2019DutchPDF
Micro modelCorrection31/12/201712/06/201820/12/2018DutchPDF
Micro model31/12/201712/06/201830/07/2018DutchPDF
Micro model31/12/201613/06/201725/07/2017DutchPDF
Abridged model31/12/201514/06/201629/07/2016DutchPDF
Abridged model31/12/201409/06/201528/07/2015DutchPDF
Abridged model31/12/201310/06/201428/07/2014DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Hendrik Merckx
Directorsince 04/06/2012Managersince 04/06/2012ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates18/09/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other26/06/2012
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings13 filings
Mandates
Hendrik Merckx
201220132014201520162017201820192020202120222023202420252026
HPC BelgiumHOSPITAL PHARMACY CONSULTING BELGIUM
Waversesteenweg(OPV) 31, 3360 Bierbeek
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Waversesteenweg(OPV) 31, 3360 BierbeekCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00175266

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
HOSPITAL PHARMACY CONSULTING BELGIUMCurrent
CBE
HPC Belgium
accounts 2021 → 2025
Accounts 2025 · 2026-00175266
HOSPITAL PHARMACY CONSULTING BELGIUM
accounts 2013 → 2020
Accounts 2020 · 2021-44200404

Events

  1. 2025
    Annual accounts 202596,1 k €↑
  2. 2024
    Annual accounts 202469,7 k €↓
  3. 2023
    Annual accounts 202380,9 k €↑
  4. 2022
    Annual accounts 202252,1 k €↑
  5. 2021
    Annual accounts 202149,9 k €↑
  6. 2021
    Name changeHPC Belgium
  7. 2020
    Annual accounts 202035,9 k €↓
  8. 2019
    Annual accounts 201936,2 k €↓
  9. 2018
    Annual accounts 201846,5 k €↑
  10. 2017
    Annual accounts 201734,9 k €↓
  11. 2016
    Annual accounts 201647,2 k €↑
  12. 2015
    Annual accounts 201534,1 k €↑
  13. 2014
    Annual accounts 2014-532 €↓
  14. 2013
    Annual accounts 20132,1 k €
  15. 04/06/2012
    IncorporationPrivate limited company